SlideShare a Scribd company logo
Prevention of
Pneumonia in
ICU
Dr/ Sami El-Dahdouh
Associate Prof. of pulmonary and critical care
Menoufia Faculty of Medicine
 HAP is defined as pneumonia that occurs
48 hours or more after admission, which
was not present nor incubating at the time
of admission .
 HAP accounts for 10-25% of all ICU infections
and for more than 50% of the antibiotics
prescribed .
 Mortality rate for HAP may be as high as 30 -
70%,
*VAP....... 25% of all nosocomial
infections in ICU.
*VAP ........ 20-50% morbidity and
mortality.
*VAP...... is a preventable disease.
Pneumonia to occur
Predis
posing
factors
Source
of
infection
Organism
entry
into
lung
Predisposing
Factors
Virulent
organism
Decreased general
immunity
Defect in
Clearing
mechanisms
Defective in clearing mechanism e.g.
- cough or gag reflex lost (Coma, paralysis,
addiction).
- obstructions (FB, tumors).
- pulmonary edema.
- mucosal injury aspiration, smoking.
Source of
infection
Person to Person
S. pumonia, TB,
Mycoplasma and viral
Environment
Leiogenalla (water)
Pstacossis(bird)
Anthrax (soil)
Healthcare devices (contaminated nebulizers, ventilation
circuits or humidifiers)
The environment (air, water, equipment, and fomites),
Commonly the transfer of microorganisms between the
patient and staff.
Stomach, sinuses, dental plaque and oropharynx
(colonization),
Organism entry
Into lung
Inhalation
OR
Aspiration
Blood spread
Direct spread
OR
Colonization
1. Aspiration of oropharyngeal pathogens.
2. Inhalation of pathogens from contaminated aerosols,
3. Hematogenous spread from infected intravascular
catheters ,
4. Bacterial translocation from the gastrointestinal tract
lumen are quite rare.
Regimens Of
Probable Efficacy
For Specific
Indications
Regimens Of
Probable Efficacy
used widely in some
clinical settings
Regimens Of
Unproven Value
Used On Limited
Investigational Or
Clinical Basis
Unproven
Regimens Still
Being Evaluated
Prevention of pneumonia
 Vaccinations against s pneumonia and
influenza virus.
 Hand washing between patient contact.
 Isolations patients with highly resistant
organisms such as MRSA.
Regimens Of Probable Efficacy
For Specific Indications
A) Nutritional support.
1-Entral feeding via feeding jejenostomy better than
TPN and lower incidence of infections as entral
stimulate intestinal mucosa preventing bacterial
translocation.
2-use of orogastric rather than nasogastric can
decrease the incidence of nosocomial sinusitis which
lead to HAP.
3- risk of aspiration increase with large bore feeding
tube and with bolus feedings than with the use
smalled tubes of continuous feeding methods.
Regimens With Probable Effectiveness
Used Widely In Some Clinical Settings
B) Regimens for intestinal bleeding prophylaxis
sucralfate (doesn't increase gastric PH) when
compared with antacid ( increase both gastric PH and
volume increase risk of aspiration) or with H -2
Antagonist(decrease gastric PH enhancing bacterial
translocation).
C) Putting The Patients In The Semi Recumbent
Position appear to reduce risk of aspiration.
D) Handling Of Respiratory Equipments:
1- Suction Catheter single use non sterile disposal
gloves should be worn for suction, And change suction
catheter between patients and after each use.
2- Suction Bottles single use disposal or reusable
wash with detergent, dry and disinfect them with
autoclave or in washing machine.
3- Breathing Circuits ventilator circuit are rapidly
colonized with bacteria and condensate within
these circuit can have high bacterial counts and
aspiration of condensate may play a role in
development of nosocomial pneumonia, so
change every 48 hs, periodic drain breathing
condensate.
4- Nebulizers change or reprocess devices
between patients by using sterilization or high
level of disinfection or use single disposal item.
5- Humidifiers clean and sterilize devices between
patients and fill with sterile water which must be
changed every 24 hs or sooner, if necessary single
use disposal humidifiers are available.
F) Subglottic Secretion Drainage:
Secretions pooled above
the endo tracheal tube cuff
represent reservoir
of the colonizing bacteria
thus removing this pool
may decrease incidence
of VAP.
ETT cuff inflation via minimal leak
technique to 20-25cmH2O(minimal
occlusive pressure).
A) Selective Digestive Decontamination (SDD)
SDD involve use of topical oral and intestinal
antibiotics, often with systemic antibiotic added for
the first few days of the regimens with the goal being
the elimination of all potential pathogens from GIT.
Sterilization of endogenous bacterial sources may
avoid infection, of debate as emergence of antibiotic
resistant organisms.
B) Topical antibiotic on the lower respiratory
tract. decrease incidence of pneumonia.
Regimens Of Unproven Value Used On
Limited Investigational Or Clinical Basis
A) Manipulations of endogenous source of
bacteria.
Unproven Regimens Still Being
Evaluated
The endotrachael tube can harbor the growth of
large no of bacteria along its inner surface, and the
bacteria at this site will persist in the airway free from
the effect of antibiotic and host defenses.
The development of new biomaterial for tubes could
lead to elimination of a tracheal tube biofilm and
eradication of reservoir of bacteria in the airways.
B) Biological response modifiers
These substances are immunomodulator have
the ability to up regulate or down regulate host
defense mechanisms. e.g..
1) Antilipopolysaccride antibodies(E5 and
HA-IA)
2) antibodies toward TNF, IN 1, PAF.
* Bundles are group of intervention related to a
disease that when instutes together give better
outcomes than when done individually.
* Provide a mechanism to enhance teamwork and
enhance outcome.
* The guideline become as road map to enhance
outcome.
Elevation of the bed between 30-45 degree
at all time (unless contraindicated).
Deep venous thrombosis (DVT)
prophylaxis (unless contraindicated).
Peptic ulcer prophylaxis
sedation interruption
Weaning protocol
Oral care
* Please remember to elevate the HOB>30 degree , and
raise knees for all ventilated patients unless
contraindicated .
*Elevation of HOB has been correlated with reduction in the
rate of the ventilator associated pneumonia.
Drakulovi Lancet, 1999
*As elevation of head of bed may contribute to
venous stasis and DVT.
*The risk of venous thromboembolism is reduced
if prophylaxis is consistently applied.
*A clinical practice guideline recommends DVT
prophylaxis for patients admitted to the ICU.
(Geerts, Chest,2004)
*Stress ulceration are the most common cause of
gastrointestinal bleeding in intensive care unit
patients .
*This predisposed to aspiration and VAP .
*Thus applying PUD prophylaxis is a necessary
intervention.
Sedation in ICU has the benefit of reducing
psychological problems to the patients .However
heavy sedation is harmful and predispose to VAP
by :
1-Inhibiting coughing.
2-Inhibiting mobilization.
3-Decreasing immune function.
4-Promoting aspiration.
5-Prolongs time on ventilator.
1-Awake and cooperative patient.
2-Cough , swallowing reflexes intact.
3-Add analgesia to the protocol .
4-Intermittent rather than continuous sedation.
5-Sedation vacation (sedation interruption).
Application:
 Hold sedation until patient is alert or can follow commands at least
once a day.
 *After sedation interruption restart sedation at a fraction of the prior
dose (1/2 or 3/4).
 *Kress et al .,conducted a randomized controlled trial in 128 adults
mechanically ventilated patients receiving continuous infusion of
sedative agents in a medical ICU, daily interruption of sedation
resulted in a highly significant reduction in time spent on mechanical
ventilation, from 7.3 days to 4.9 day (p=0.004).
(Kress, N Engl J Med,2000)
* Non-physician driven weaning protocol (by nurses or
respiratory therapists).
* Daily assessment of readiness to wean from ventilator:
 keep TV and pressure low.
 preextubation assessment and worksheet .
(Dries JTrauma,2006)
Designed for patients who are intubated
or tracheostomiazed
*Mouth care protocol.
*Brush twice .
*Swab every two hours.
*Chlorhexidine rinse.
*Apply mouth moisturizer.
(Chlebicki, Crit Care Med,2007)
Thank you

More Related Content

What's hot

Pharmacological agents in bronchial asthma and copd
Pharmacological agents in bronchial asthma and copdPharmacological agents in bronchial asthma and copd
Pharmacological agents in bronchial asthma and copd
Dr. Marya Ahsan
 
Medicationuse in chronic lung diseasess edited 2019
Medicationuse in chronic lung diseasess edited 2019Medicationuse in chronic lung diseasess edited 2019
Medicationuse in chronic lung diseasess edited 2019
Shira Persona
 
Bio 120 presentation 1 (ksc) ch 7
Bio 120 presentation 1 (ksc) ch 7Bio 120 presentation 1 (ksc) ch 7
Bio 120 presentation 1 (ksc) ch 7
chronicks
 
Pharmacotherapy of bronchial asthma
Pharmacotherapy of bronchial asthma Pharmacotherapy of bronchial asthma
Pharmacotherapy of bronchial asthma
Qudsia Nuzhat
 
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku JosephBasic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
Dr.Tinku Joseph
 
Drug induced pulmonary diseases
Drug induced pulmonary diseases Drug induced pulmonary diseases
Drug induced pulmonary diseases
anum khan
 
DRUG INDUCED PULMONARY DISEASES
DRUG INDUCED PULMONARY DISEASESDRUG INDUCED PULMONARY DISEASES
DRUG INDUCED PULMONARY DISEASES
Koppala RVS Chaitanya
 
Role of ICS in Asthma and COPD
Role of ICS in Asthma  and COPDRole of ICS in Asthma  and COPD
Role of ICS in Asthma and COPD
Gamal Agmy
 
Medical surgical management of copd (GOLD 2016-2017)
Medical surgical management of copd (GOLD 2016-2017)Medical surgical management of copd (GOLD 2016-2017)
Medical surgical management of copd (GOLD 2016-2017)
dr yogendra rathore
 
Drugs for bronchial asthma
Drugs for bronchial asthma Drugs for bronchial asthma
Drugs for bronchial asthma
John Milton
 
Drug induced pulmonary diseases
Drug induced pulmonary diseasesDrug induced pulmonary diseases
Drug induced pulmonary diseases
Chanukya Vanam . Dr
 
Copd
CopdCopd
Copd
anum khan
 
Updates On Pharmacological Management Of Asthma In Adults
Updates On Pharmacological Management Of  Asthma In AdultsUpdates On Pharmacological Management Of  Asthma In Adults
Updates On Pharmacological Management Of Asthma In Adults
Ashraf ElAdawy
 
Respirtory part2
Respirtory part2Respirtory part2
Respirtory part2lam808
 
Pharmacotherapy for respiratory diseases Asthma and COPD
Pharmacotherapy for respiratory diseases  Asthma and COPDPharmacotherapy for respiratory diseases  Asthma and COPD
Pharmacotherapy for respiratory diseases Asthma and COPD
Priyanka Ghadage Nalawade
 
Recent advances in Asthma & COPD by Dr.Tinku Joseph
Recent advances in Asthma & COPD by  Dr.Tinku JosephRecent advances in Asthma & COPD by  Dr.Tinku Joseph
Recent advances in Asthma & COPD by Dr.Tinku Joseph
Dr.Tinku Joseph
 
Antibiotic Dosing in critical care Catherine mc kenzie
Antibiotic Dosing in critical care Catherine mc kenzieAntibiotic Dosing in critical care Catherine mc kenzie
Antibiotic Dosing in critical care Catherine mc kenzie
isakakinada
 
Drug Induced Pulmonary Diseases
Drug Induced Pulmonary DiseasesDrug Induced Pulmonary Diseases
Drug Induced Pulmonary Diseases
Health Forager
 

What's hot (20)

Pharmacological agents in bronchial asthma and copd
Pharmacological agents in bronchial asthma and copdPharmacological agents in bronchial asthma and copd
Pharmacological agents in bronchial asthma and copd
 
Medicationuse in chronic lung diseasess edited 2019
Medicationuse in chronic lung diseasess edited 2019Medicationuse in chronic lung diseasess edited 2019
Medicationuse in chronic lung diseasess edited 2019
 
Bio 120 presentation 1 (ksc) ch 7
Bio 120 presentation 1 (ksc) ch 7Bio 120 presentation 1 (ksc) ch 7
Bio 120 presentation 1 (ksc) ch 7
 
Pharmacotherapy of bronchial asthma
Pharmacotherapy of bronchial asthma Pharmacotherapy of bronchial asthma
Pharmacotherapy of bronchial asthma
 
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku JosephBasic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
Basic concepts in treatment of Pulmonary Tuberculosis - By Dr.Tinku Joseph
 
Drug induced pulmonary diseases
Drug induced pulmonary diseases Drug induced pulmonary diseases
Drug induced pulmonary diseases
 
Asthma Posted 1018 06
Asthma Posted 1018 06Asthma Posted 1018 06
Asthma Posted 1018 06
 
DRUG INDUCED PULMONARY DISEASES
DRUG INDUCED PULMONARY DISEASESDRUG INDUCED PULMONARY DISEASES
DRUG INDUCED PULMONARY DISEASES
 
Role of ICS in Asthma and COPD
Role of ICS in Asthma  and COPDRole of ICS in Asthma  and COPD
Role of ICS in Asthma and COPD
 
Medical surgical management of copd (GOLD 2016-2017)
Medical surgical management of copd (GOLD 2016-2017)Medical surgical management of copd (GOLD 2016-2017)
Medical surgical management of copd (GOLD 2016-2017)
 
Drugs for bronchial asthma
Drugs for bronchial asthma Drugs for bronchial asthma
Drugs for bronchial asthma
 
Drug induced pulmonary diseases
Drug induced pulmonary diseasesDrug induced pulmonary diseases
Drug induced pulmonary diseases
 
Copd
CopdCopd
Copd
 
Updates On Pharmacological Management Of Asthma In Adults
Updates On Pharmacological Management Of  Asthma In AdultsUpdates On Pharmacological Management Of  Asthma In Adults
Updates On Pharmacological Management Of Asthma In Adults
 
Respirtory part2
Respirtory part2Respirtory part2
Respirtory part2
 
Pharmacotherapy for respiratory diseases Asthma and COPD
Pharmacotherapy for respiratory diseases  Asthma and COPDPharmacotherapy for respiratory diseases  Asthma and COPD
Pharmacotherapy for respiratory diseases Asthma and COPD
 
Recent advances in Asthma & COPD by Dr.Tinku Joseph
Recent advances in Asthma & COPD by  Dr.Tinku JosephRecent advances in Asthma & COPD by  Dr.Tinku Joseph
Recent advances in Asthma & COPD by Dr.Tinku Joseph
 
Antibiotic Dosing in critical care Catherine mc kenzie
Antibiotic Dosing in critical care Catherine mc kenzieAntibiotic Dosing in critical care Catherine mc kenzie
Antibiotic Dosing in critical care Catherine mc kenzie
 
Drug Induced Pulmonary Diseases
Drug Induced Pulmonary DiseasesDrug Induced Pulmonary Diseases
Drug Induced Pulmonary Diseases
 
Drugs pharmacology in lung disease
Drugs pharmacology in lung diseaseDrugs pharmacology in lung disease
Drugs pharmacology in lung disease
 

Similar to Prevention of pneunmonia in icu

prevention of complication in CCU
 prevention of complication in CCU prevention of complication in CCU
prevention of complication in CCU
dhammadina patharde
 
Ventilator associated infections VAP
Ventilator associated infections VAP Ventilator associated infections VAP
Ventilator associated infections VAP
Thair Abuaqeel
 
vap.pptx
vap.pptxvap.pptx
vap.pptx
Nida Nazim
 
VENTILATOR ACQUIRED PNEUMONIUA.pptx
VENTILATOR ACQUIRED PNEUMONIUA.pptxVENTILATOR ACQUIRED PNEUMONIUA.pptx
VENTILATOR ACQUIRED PNEUMONIUA.pptx
TolaOjo1
 
Management pneumonia cbl
Management pneumonia cblManagement pneumonia cbl
Management pneumonia cbl
Devina Ciayadi
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
anaesthesiaESICMCH
 
Antibiotic prophylaxis
Antibiotic prophylaxisAntibiotic prophylaxis
Antibiotic prophylaxis
Indian dental academy
 
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRAN
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRANVENTILATOR ASSOCIATED PNEUMONIA BY DR IMRAN
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRANimran80
 
Ventilator Associated Pneumonia Management.pptx
Ventilator Associated Pneumonia Management.pptxVentilator Associated Pneumonia Management.pptx
Ventilator Associated Pneumonia Management.pptx
DileepRedemption
 
Preventing postoperative infection
Preventing postoperative infectionPreventing postoperative infection
Preventing postoperative infection
Chamika Huruggamuwa
 
Hospital Acquired Infections 0.2.pptx...
Hospital Acquired Infections 0.2.pptx...Hospital Acquired Infections 0.2.pptx...
Hospital Acquired Infections 0.2.pptx...
patelradhe0208
 
Antibiotic use in an intensive care setting iacm, medicine update 2012
Antibiotic use in an intensive care setting   iacm, medicine update 2012Antibiotic use in an intensive care setting   iacm, medicine update 2012
Antibiotic use in an intensive care setting iacm, medicine update 2012
Sachin Adukia
 
Antibiotics in icu
Antibiotics in icuAntibiotics in icu
Antibiotics in icu
aljamhori teaching hospital
 
Bundles to prevent ventilator associated pneumonia
Bundles to prevent ventilator associated pneumoniaBundles to prevent ventilator associated pneumonia
Bundles to prevent ventilator associated pneumoniapravin2k2
 
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02Manotosh Sutradhar
 
Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)
Apollo Hospitals
 
A stitch in time saves nine
A stitch in time saves nineA stitch in time saves nine
A stitch in time saves nine
American University hospital of Beirut
 
Lung Abscess, Pulmonolgy
Lung Abscess, PulmonolgyLung Abscess, Pulmonolgy
Lung Abscess, Pulmonolgy
Vedica Sethi
 
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
Philippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
 
hospital acquired pneumonia from preventive med prospective
hospital acquired pneumonia from preventive med prospectivehospital acquired pneumonia from preventive med prospective
hospital acquired pneumonia from preventive med prospective
fawziahroublah1
 

Similar to Prevention of pneunmonia in icu (20)

prevention of complication in CCU
 prevention of complication in CCU prevention of complication in CCU
prevention of complication in CCU
 
Ventilator associated infections VAP
Ventilator associated infections VAP Ventilator associated infections VAP
Ventilator associated infections VAP
 
vap.pptx
vap.pptxvap.pptx
vap.pptx
 
VENTILATOR ACQUIRED PNEUMONIUA.pptx
VENTILATOR ACQUIRED PNEUMONIUA.pptxVENTILATOR ACQUIRED PNEUMONIUA.pptx
VENTILATOR ACQUIRED PNEUMONIUA.pptx
 
Management pneumonia cbl
Management pneumonia cblManagement pneumonia cbl
Management pneumonia cbl
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
 
Antibiotic prophylaxis
Antibiotic prophylaxisAntibiotic prophylaxis
Antibiotic prophylaxis
 
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRAN
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRANVENTILATOR ASSOCIATED PNEUMONIA BY DR IMRAN
VENTILATOR ASSOCIATED PNEUMONIA BY DR IMRAN
 
Ventilator Associated Pneumonia Management.pptx
Ventilator Associated Pneumonia Management.pptxVentilator Associated Pneumonia Management.pptx
Ventilator Associated Pneumonia Management.pptx
 
Preventing postoperative infection
Preventing postoperative infectionPreventing postoperative infection
Preventing postoperative infection
 
Hospital Acquired Infections 0.2.pptx...
Hospital Acquired Infections 0.2.pptx...Hospital Acquired Infections 0.2.pptx...
Hospital Acquired Infections 0.2.pptx...
 
Antibiotic use in an intensive care setting iacm, medicine update 2012
Antibiotic use in an intensive care setting   iacm, medicine update 2012Antibiotic use in an intensive care setting   iacm, medicine update 2012
Antibiotic use in an intensive care setting iacm, medicine update 2012
 
Antibiotics in icu
Antibiotics in icuAntibiotics in icu
Antibiotics in icu
 
Bundles to prevent ventilator associated pneumonia
Bundles to prevent ventilator associated pneumoniaBundles to prevent ventilator associated pneumonia
Bundles to prevent ventilator associated pneumonia
 
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02
Bundlestopreventventilator associatedpneumonia-140724021616-phpapp02
 
Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)
 
A stitch in time saves nine
A stitch in time saves nineA stitch in time saves nine
A stitch in time saves nine
 
Lung Abscess, Pulmonolgy
Lung Abscess, PulmonolgyLung Abscess, Pulmonolgy
Lung Abscess, Pulmonolgy
 
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
Ventilator Associated Pneumonia (VAP) or Hospital Acquired Pneumonia (HAP)
 
hospital acquired pneumonia from preventive med prospective
hospital acquired pneumonia from preventive med prospectivehospital acquired pneumonia from preventive med prospective
hospital acquired pneumonia from preventive med prospective
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 

Prevention of pneunmonia in icu

  • 1. Prevention of Pneumonia in ICU Dr/ Sami El-Dahdouh Associate Prof. of pulmonary and critical care Menoufia Faculty of Medicine
  • 2.  HAP is defined as pneumonia that occurs 48 hours or more after admission, which was not present nor incubating at the time of admission .  HAP accounts for 10-25% of all ICU infections and for more than 50% of the antibiotics prescribed .  Mortality rate for HAP may be as high as 30 - 70%,
  • 3. *VAP....... 25% of all nosocomial infections in ICU. *VAP ........ 20-50% morbidity and mortality. *VAP...... is a preventable disease.
  • 5. Predisposing Factors Virulent organism Decreased general immunity Defect in Clearing mechanisms Defective in clearing mechanism e.g. - cough or gag reflex lost (Coma, paralysis, addiction). - obstructions (FB, tumors). - pulmonary edema. - mucosal injury aspiration, smoking.
  • 6. Source of infection Person to Person S. pumonia, TB, Mycoplasma and viral Environment Leiogenalla (water) Pstacossis(bird) Anthrax (soil) Healthcare devices (contaminated nebulizers, ventilation circuits or humidifiers) The environment (air, water, equipment, and fomites), Commonly the transfer of microorganisms between the patient and staff. Stomach, sinuses, dental plaque and oropharynx (colonization),
  • 7. Organism entry Into lung Inhalation OR Aspiration Blood spread Direct spread OR Colonization 1. Aspiration of oropharyngeal pathogens. 2. Inhalation of pathogens from contaminated aerosols, 3. Hematogenous spread from infected intravascular catheters , 4. Bacterial translocation from the gastrointestinal tract lumen are quite rare.
  • 8.
  • 9. Regimens Of Probable Efficacy For Specific Indications Regimens Of Probable Efficacy used widely in some clinical settings Regimens Of Unproven Value Used On Limited Investigational Or Clinical Basis Unproven Regimens Still Being Evaluated Prevention of pneumonia
  • 10.  Vaccinations against s pneumonia and influenza virus.  Hand washing between patient contact.  Isolations patients with highly resistant organisms such as MRSA. Regimens Of Probable Efficacy For Specific Indications
  • 11. A) Nutritional support. 1-Entral feeding via feeding jejenostomy better than TPN and lower incidence of infections as entral stimulate intestinal mucosa preventing bacterial translocation. 2-use of orogastric rather than nasogastric can decrease the incidence of nosocomial sinusitis which lead to HAP. 3- risk of aspiration increase with large bore feeding tube and with bolus feedings than with the use smalled tubes of continuous feeding methods. Regimens With Probable Effectiveness Used Widely In Some Clinical Settings
  • 12. B) Regimens for intestinal bleeding prophylaxis sucralfate (doesn't increase gastric PH) when compared with antacid ( increase both gastric PH and volume increase risk of aspiration) or with H -2 Antagonist(decrease gastric PH enhancing bacterial translocation). C) Putting The Patients In The Semi Recumbent Position appear to reduce risk of aspiration. D) Handling Of Respiratory Equipments: 1- Suction Catheter single use non sterile disposal gloves should be worn for suction, And change suction catheter between patients and after each use.
  • 13. 2- Suction Bottles single use disposal or reusable wash with detergent, dry and disinfect them with autoclave or in washing machine. 3- Breathing Circuits ventilator circuit are rapidly colonized with bacteria and condensate within these circuit can have high bacterial counts and aspiration of condensate may play a role in development of nosocomial pneumonia, so change every 48 hs, periodic drain breathing condensate. 4- Nebulizers change or reprocess devices between patients by using sterilization or high level of disinfection or use single disposal item.
  • 14.
  • 15. 5- Humidifiers clean and sterilize devices between patients and fill with sterile water which must be changed every 24 hs or sooner, if necessary single use disposal humidifiers are available. F) Subglottic Secretion Drainage: Secretions pooled above the endo tracheal tube cuff represent reservoir of the colonizing bacteria thus removing this pool may decrease incidence of VAP.
  • 16. ETT cuff inflation via minimal leak technique to 20-25cmH2O(minimal occlusive pressure).
  • 17. A) Selective Digestive Decontamination (SDD) SDD involve use of topical oral and intestinal antibiotics, often with systemic antibiotic added for the first few days of the regimens with the goal being the elimination of all potential pathogens from GIT. Sterilization of endogenous bacterial sources may avoid infection, of debate as emergence of antibiotic resistant organisms. B) Topical antibiotic on the lower respiratory tract. decrease incidence of pneumonia. Regimens Of Unproven Value Used On Limited Investigational Or Clinical Basis
  • 18. A) Manipulations of endogenous source of bacteria. Unproven Regimens Still Being Evaluated
  • 19. The endotrachael tube can harbor the growth of large no of bacteria along its inner surface, and the bacteria at this site will persist in the airway free from the effect of antibiotic and host defenses. The development of new biomaterial for tubes could lead to elimination of a tracheal tube biofilm and eradication of reservoir of bacteria in the airways.
  • 20. B) Biological response modifiers These substances are immunomodulator have the ability to up regulate or down regulate host defense mechanisms. e.g.. 1) Antilipopolysaccride antibodies(E5 and HA-IA) 2) antibodies toward TNF, IN 1, PAF.
  • 21. * Bundles are group of intervention related to a disease that when instutes together give better outcomes than when done individually. * Provide a mechanism to enhance teamwork and enhance outcome. * The guideline become as road map to enhance outcome.
  • 22. Elevation of the bed between 30-45 degree at all time (unless contraindicated). Deep venous thrombosis (DVT) prophylaxis (unless contraindicated). Peptic ulcer prophylaxis sedation interruption Weaning protocol Oral care
  • 23. * Please remember to elevate the HOB>30 degree , and raise knees for all ventilated patients unless contraindicated . *Elevation of HOB has been correlated with reduction in the rate of the ventilator associated pneumonia. Drakulovi Lancet, 1999
  • 24. *As elevation of head of bed may contribute to venous stasis and DVT. *The risk of venous thromboembolism is reduced if prophylaxis is consistently applied. *A clinical practice guideline recommends DVT prophylaxis for patients admitted to the ICU. (Geerts, Chest,2004)
  • 25. *Stress ulceration are the most common cause of gastrointestinal bleeding in intensive care unit patients . *This predisposed to aspiration and VAP . *Thus applying PUD prophylaxis is a necessary intervention.
  • 26. Sedation in ICU has the benefit of reducing psychological problems to the patients .However heavy sedation is harmful and predispose to VAP by : 1-Inhibiting coughing. 2-Inhibiting mobilization. 3-Decreasing immune function. 4-Promoting aspiration. 5-Prolongs time on ventilator.
  • 27. 1-Awake and cooperative patient. 2-Cough , swallowing reflexes intact. 3-Add analgesia to the protocol . 4-Intermittent rather than continuous sedation. 5-Sedation vacation (sedation interruption).
  • 28. Application:  Hold sedation until patient is alert or can follow commands at least once a day.  *After sedation interruption restart sedation at a fraction of the prior dose (1/2 or 3/4).  *Kress et al .,conducted a randomized controlled trial in 128 adults mechanically ventilated patients receiving continuous infusion of sedative agents in a medical ICU, daily interruption of sedation resulted in a highly significant reduction in time spent on mechanical ventilation, from 7.3 days to 4.9 day (p=0.004). (Kress, N Engl J Med,2000)
  • 29. * Non-physician driven weaning protocol (by nurses or respiratory therapists). * Daily assessment of readiness to wean from ventilator:  keep TV and pressure low.  preextubation assessment and worksheet . (Dries JTrauma,2006)
  • 30. Designed for patients who are intubated or tracheostomiazed *Mouth care protocol. *Brush twice . *Swab every two hours. *Chlorhexidine rinse. *Apply mouth moisturizer. (Chlebicki, Crit Care Med,2007)